Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 53


Association of p53 rs1042522, MDM2 rs2279744, and p21 rs1801270 polymorphisms with retinoblastoma risk and invasion in a Chinese population.

Chen R, Liu S, Ye H, Li J, Du Y, Chen L, Liu X, Ding Y, Li Q, Mao Y, Ai S, Zhang P, Ma W, Yang H.

Sci Rep. 2015 Aug 20;5:13300. doi: 10.1038/srep13300.


Retinoblastoma Progression.

Cobrinik D.

EBioMedicine. 2015 Jul 17;2(7):623-4. doi: 10.1016/j.ebiom.2015.07.023. eCollection 2015 Jul. No abstract available.


Characterization and pharmacologic targeting of EZH2, a fetal retinal protein and epigenetic regulator, in human retinoblastoma.

Khan M, Walters LL, Li Q, Thomas DG, Miller JM, Zhang Q, Sciallis AP, Liu Y, Dlouhy BJ, Fort PE, Archer SM, Demirci H, Dou Y, Rao RC.

Lab Invest. 2015 Nov;95(11):1278-90. doi: 10.1038/labinvest.2015.104. Epub 2015 Aug 17.


Spatiotemporal Patterns of Tumor Occurrence in Children with Intraocular Retinoblastoma.

King BA, Parra C, Li Y, Helton KJ, Qaddoumi I, Wilson MW, Ogg RJ.

PLoS One. 2015 Jul 31;10(7):e0132932. doi: 10.1371/journal.pone.0132932. eCollection 2015.


Co-deleting Pten with Rb in retinal progenitor cells in mice results in fully penetrant bilateral retinoblastomas.

Xie C, Lu H, Nomura A, Hanse EA, Forster CL, Parker JB, Linden MA, Karasch C, Hallstrom TC.

Mol Cancer. 2015 Apr 24;14:93. doi: 10.1186/s12943-015-0360-y.


RB loss contributes to aggressive tumor phenotypes in MYC-driven triple negative breast cancer.

Knudsen ES, McClendon AK, Franco J, Ertel A, Fortina P, Witkiewicz AK.

Cell Cycle. 2015;14(1):109-22. doi: 10.4161/15384101.2014.967118.


Histopathologic grading of anaplasia in retinoblastoma.

Mendoza PR, Specht CS, Hubbard GB, Wells JR, Lynn MJ, Zhang Q, Kong J, Grossniklaus HE.

Am J Ophthalmol. 2015 Apr;159(4):764-76. doi: 10.1016/j.ajo.2014.12.014. Epub 2014 Dec 19.


Antitumor mechanisms when pRb and p53 are genetically inactivated.

Zhu L, Lu Z, Zhao H.

Oncogene. 2015 Aug 27;34(35):4547-57. doi: 10.1038/onc.2014.399. Epub 2014 Dec 8. Review.


Rb suppresses human cone-precursor-derived retinoblastoma tumours.

Xu XL, Singh HP, Wang L, Qi DL, Poulos BK, Abramson DH, Jhanwar SC, Cobrinik D.

Nature. 2014 Oct 16;514(7522):385-8. doi: 10.1038/nature13813. Epub 2014 Sep 24.


Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture.

Grossniklaus HE.

Am J Ophthalmol. 2014 Nov;158(5):875-91. doi: 10.1016/j.ajo.2014.07.025. Epub 2014 Jul 24.


Suppression of PAX6 promotes cell proliferation and inhibits apoptosis in human retinoblastoma cells.

Meng B, Wang Y, Li B.

Int J Mol Med. 2014 Aug;34(2):399-408. doi: 10.3892/ijmm.2014.1812. Epub 2014 Jun 17.


Inhibitor of apoptosis-stimulating protein of p53 (iASPP) is required for neuronal survival after axonal injury.

Wilson AM, Chiodo VA, Boye SL, Brecha NC, Hauswirth WW, Di Polo A.

PLoS One. 2014 Apr 8;9(4):e94175. doi: 10.1371/journal.pone.0094175. eCollection 2014.


Suppressing thyroid hormone signaling preserves cone photoreceptors in mouse models of retinal degeneration.

Ma H, Thapa A, Morris L, Redmond TM, Baehr W, Ding XQ.

Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):3602-7. doi: 10.1073/pnas.1317041111. Epub 2014 Feb 18.


The genomic landscape of retinoblastoma: a review.

Thériault BL, Dimaras H, Gallie BL, Corson TW.

Clin Experiment Ophthalmol. 2014 Jan-Feb;42(1):33-52. doi: 10.1111/ceo.12132. Epub 2013 May 22. Review.


Defining a new vision for the retinoblastoma gene: report from the 3rd International Rb Meeting.

Rubin SM, Sage J.

Cell Div. 2013 Nov 21;8(1):13. doi: 10.1186/1747-1028-8-13.


RB1 gene mutations in retinoblastoma and its clinical correlation.

Ali MJ, Parsam VL, Honavar SG, Kannabiran C, Vemuganti GK, Reddy VA.

Saudi J Ophthalmol. 2010 Oct;24(4):119-23. doi: 10.1016/j.sjopt.2010.05.003. Epub 2010 Feb 6.


Retinoblastoma: concerning its initiation and treatment.

Luo C, Deng YP.

Int J Ophthalmol. 2013 Jun 18;6(3):397-401. doi: 10.3980/j.issn.2222-3959.2013.03.26. Print 2013.


Whole chromosome instability resulting from the synergistic effects of pRB and p53 inactivation.

Manning AL, Benes C, Dyson NJ.

Oncogene. 2014 May 8;33(19):2487-94. doi: 10.1038/onc.2013.201. Epub 2013 Jun 24.


Gene expression profiling identifies different sub-types of retinoblastoma.

Kapatai G, Brundler MA, Jenkinson H, Kearns P, Parulekar M, Peet AC, McConville CM.

Br J Cancer. 2013 Jul 23;109(2):512-25. doi: 10.1038/bjc.2013.283. Epub 2013 Jun 11.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk